Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,832 | 421 | 0 | 0 | N/A |
| Other current assets | 0 | 750 | 0 | 0 | 0 |
| TOTAL | $1,972 | $1,237 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | N/A | N/A | N/A |
| TOTAL | $2 | $3 | $N/A | $N/A | $N/A |
| Total Assets | $1,974 | $1,240 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,522 | 1,765 | 0 | 0 | 0 |
| TOTAL | $3,805 | $3,789 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,805 | $3,789 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,728 | 14,578 | N/A | N/A | N/A |
| Common Shares | 15 | 14 | 0 | 0 | N/A |
| Retained earnings | -14,502 | -13,451 | 0 | 0 | N/A |
| Other shareholders' equity | -1,568 | -1,536 | 0 | 0 | 0 |
| TOTAL | $-1,831 | $-2,549 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $1,974 | $1,240 | $0 | $0 | $0 |